镭-223治疗骨转移瘤的机制建模研究
该研究采用Gompertz生长模型模拟转移性肿瘤负荷,基于已发表的镭-223摄取测量数据,将α粒子辐射效应纳入模型,并比较了三种镭分布场景(均匀暴露、仅外层暴露和恒定体积暴露)下肿瘤进展至首次症状性骨骼事件的时间与临床Kaplan-Meier曲线的吻合度。结果显示,均匀暴露和外层暴露场景与临床数据吻合极差,而恒定体积效应预测结果与观察到的临床结果非常相似,提示仅小部分细胞群体受到镭-223损伤。作者结论认为常用的均匀分布假设不能准确反映临床反应,仅肿瘤亚群受镭-223影响的假设表明迫切需要进一步研究肿瘤和药物动力学以制定更有效的治疗方案。
要点
- 均匀和外层暴露场景与临床Kaplan-Meier曲线吻合极差。
- 恒定体积效应预测结果与临床观察结果非常相似。
- 常用的均匀镭-223分布假设不能准确反映临床反应。
核心结论
- 常用的均匀镭-223分布假设不能准确反映临床反应。
- 仅肿瘤亚群可能受镭-223影响的假设表明迫切需要进一步研究肿瘤和药物动力学以制定更有效的治疗方案。
研究设计与样本
- 研究采用已确立的Gompertz生长模型模拟转移性肿瘤负荷,基于已发表的镭-223摄取测量数据将α粒子辐射效应纳入模型。
- 研究调查了三种镭分布场景:均匀暴露、仅外层暴露和恒定体积暴露,并计算每种场景下不同肿瘤阶段进展至首次症状性骨骼事件的时间。
- 研究将模型结果与临床数据的Kaplan-Meier患者曲线进行比较。
主要发现
- 均匀暴露和外层暴露场景与临床数据的Kaplan-Meier患者曲线吻合极差。
- 恒定体积效应预测结果与观察到的临床结果非常相似,提示取决于剂量率,相对小部分细胞群体受到镭-223损伤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Despite the effectiveness of 223RaCl2 for treating patients with symptomatic bone metastatic disease, its mechanisms of action are still unclear. Even established dosimetric approaches differ considerably in their conclusions. In silico tumor models bring a new perspective to this situation because they can quantitatively simulate the interaction of α-particles with the target(s). Here, we investigated 3 different mathematical models of tumor growth that consider the radiation effect of radium-223 (223Ra) treatments and compared the results with clinical data. METHODS AND MATERIALS: The well-established Gompertz growth model was applied to simulate metastatic tumor burden. On the basis of published measurements of 223Ra uptake, we have incorporated the radiation effect of α-particles into the model and investigated 3 radium distribution scenarios-uniform exposure, exposure of only an outer layer, and exposure of a constant volume of the tumor. For each scenario, the times for various tumor stages to progress to the first symptomatic skeletal event were calculated. RESULTS: Uniform and outer-layer exposure scenarios showed very poor agreement with the Kaplan-Meier patient curves from clinical data. However, the constant-volume effect predicted outcomes very similar to the observed clinical results, suggesting, depending on the dose rate, that relatively small fractions of the cell population see damage from 223Ra. CONCLUSIONS: The commonly used assumption of uniform 223Ra distribution does not accurately reflect clinical responses. The suggestion that only a subpopulation of the tumor might be affected by 223Ra shows a pressing need to further study the tumor and drug kinetics to schedule more effective treatments in the future.
引用
- Moreira HMR, Guerra Liberal FDC, O'Sullivan JM, et al. Mechanistic Modeling of Radium-223 Treatment of Bone Metastases. Int J Radiat Oncol Biol Phys. 2018. PMID: 30557674. doi:10.1016/j.ijrobp.2018.12.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。